Key facts
- This page summarizes Keith Michael Gottesdiener's Form 4 filing for Prime Medicine, Inc. (PRME).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Oct 2024, 16:29.
Keith Michael Gottesdiener - 08 Oct 2024 Form 4 Insider Report for Prime Medicine, Inc. (PRME)
- Reporting relationship
- President and Chief Executive Officer, Director
- Issuer ticker
- PRME
- Reported as of
- 08 Oct 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Oct 2024, 16:29:11 UTC
- Prior SEC filing
- 07 Jun 2024
- Next SEC filing
- 09 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Karen Brown, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Keith Michael Gottesdiener filed Form 4 for Prime Medicine, Inc. (PRME) on 10 Oct 2024.
Change
- Previous filing in this sequence was filed on 07 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PRME
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -226,925
- Change %
- -82%
- Price
- $0.000000
- Shares after
- 50,241
- Date
- 08 Oct 2024
- Ownership
- By Spouse
- Footnotes
- F1
PRME
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- +226,925
- Change %
- +50%
- Price
- $0.000000
- Shares after
- 682,259
- Date
- 08 Oct 2024
- Ownership
- By Trust
- Footnotes
- F1, F2
PRME
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,310,837
- Date
- 08 Oct 2024
- Ownership
- Direct
PRME
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,317,741
- Date
- 08 Oct 2024
- Ownership
- By Trust
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On October 8, 2024, for bona fide estate planning purposes, the Reporting Person's spouse transferred 226,925 shares of Issuer common stock to a family trust for no consideration.
Footnote F2
Shares held by a trust for which certain of the Reporting Person's family member is a trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
Footnote F3
Shares held by a trust for which the Reporting Person's spouse and certain of the Reporting Person's family member are co-trustees. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
SEC remarks
President and Chief Executive Officer